Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45,858 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study.
Gottschlich A, Hong Q, Gondara L, Alam MS, Cook DA, Martin RE, Lee M, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, Krajden M, Smith LW, Ogilvie GS. Gottschlich A, et al. Among authors: lee m. Cancer Epidemiol Biomarkers Prev. 2024 Jul 1;33(7):904-911. doi: 10.1158/1055-9965.EPI-23-1587. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38773687 Free PMC article.
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS, Krajden M, van Niekerk D, Smith LW, Cook D, Ceballos K, Lee M, Gentile L, Gondara L, Elwood-Martin R, Peacock S, Stuart G, Franco EL, Coldman AJ. Ogilvie GS, et al. Among authors: lee m. Int J Cancer. 2017 Jan 15;140(2):440-448. doi: 10.1002/ijc.30454. Epub 2016 Oct 20. Int J Cancer. 2017. PMID: 27685757 Clinical Trial.
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort.
Gottschlich A, van Niekerk D, Smith LW, Gondara L, Melnikow J, Cook DA, Lee M, Stuart G, Martin RE, Peacock S, Franco EL, Coldman A, Krajden M, Ogilvie G. Gottschlich A, et al. Among authors: lee m. Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):22-29. doi: 10.1158/1055-9965.EPI-20-1177. Epub 2020 Oct 20. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33082202 Free PMC article. Clinical Trial.
Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV.
McClymont E, Albert AY, Wang C, Dos Santos SJ, Coutlée F, Lee M, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Yudin MH, Harris M, Wobeser W, Hill JE, Money DM; CTN 236 HPV in HIV Study Team. McClymont E, et al. Among authors: lee m. Int J STD AIDS. 2022 Aug;33(9):847-855. doi: 10.1177/09564624221109686. Epub 2022 Jul 1. Int J STD AIDS. 2022. PMID: 35775280 Free PMC article.
The role of the fallopian tube in ovarian cancer.
Tone AA, Salvador S, Finlayson SJ, Tinker AV, Kwon JS, Lee CH, Cohen T, Ehlen T, Lee M, Carey MS, Heywood M, Pike J, Hoskins PJ, Stuart GC, Swenerton KD, Huntsman DG, Gilks CB, Miller DM, McAlpine JN. Tone AA, et al. Among authors: lee ch, lee m. Clin Adv Hematol Oncol. 2012 May;10(5):296-306. Clin Adv Hematol Oncol. 2012. PMID: 22706539 Review.
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ. Ogilvie GS, et al. Among authors: lee m. JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464. JAMA. 2018. PMID: 29971397 Free PMC article. Clinical Trial.
45,858 results
You have reached the last available page of results. Please see the User Guide for more information.